[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 292
Citations 0
In This Issue of JAMA Cardiology
December 2017


JAMA Cardiol. 2017;2(12):1291. doi:10.1001/jamacardio.2016.3679

Outcomes data for women and minority patients after percutaneous coronary intervention with everolimus-eluting stents are limited. Batchelor and coauthors assessed 1-year outcomes in patients enrolled in the PLATINUM Diversity study and the PROMUS Element Plus Post-Approval Study, including 1635 white men, 1863 women (white and minority), and 1059 minority patients (women and men). Compared with white men, the adjusted risk of death/myocardial infarction was higher among women and minority patients, and the adjusted risk of myocardial infarction was higher in minority patients. These differences were driven primarily by nonstent-related myocardial infarctions. Adverse events were also associated with social determinants of health, including widowhood and insurance status.